Search Results
Found 1 results
510(k) Data Aggregation
(29 days)
FLEXCATH STEERABLE SHEATH (12 FRENCH), FLEXCATH STEERABLE SHEATH (10 FRENCH) MODEL 3FC12, 3FC10
The FlexCath Steerable Sheath is intended for percutaneous catheter introduction into the vasculature and into the chambers of the heart. The Sheath deflection facilitates catheter positioning.
The FlexCath Steerable Sheath is a deflectable catheter introducer used to facilitate placement of a catheter through the skin into the artery or vein. It is comprised of the following two (2) main sections: the shaft and the handle. A dilator is included with each sheath. This application addresses changes to the 12F FlexCath sheath tip and valve assembly.
The FlexCath Steerable Sheath & Dilator (K102176) is intended for percutaneous catheter introduction into the vasculature and chambers of the heart. The sheath's deflection facilitates catheter positioning. The predicate devices are K081049 - FlexCath Steerable Sheath & Dilator, Models 3FC10, 3FC12.
1. Table of Acceptance Criteria and Reported Device Performance
Test | Acceptance Criteria | Reported Device Performance |
---|---|---|
Hemostasis valve leak testing | Per ISO 11070 | Met |
Hub-to-shaft tensile | Per ISO 11070 | Met |
Shaft leak testing | Per ISO 11070 | Met |
Detachment force: dilator luer lock from sheath valve cap | Not specified | Met |
Removal force: dilator from sheath | Not specified | Met |
Tensile testing of bond joints (valve hub to valve cap, hub body to extension tube, stopcock to extension tube) | Not specified | Met |
Sheath tip robustness (multiple catheter deployments/retractions) | Not specified | Met |
Air aspiration and flushing ability | Not specified | Met |
Tip strength | Not specified | Met |
Deflection testing | Not specified | Met |
Sterilization cycle impact | In accordance with AAMI TIR28:2001 | Met |
Biocompatibility: Physicochemical testing | USP 33 | Met |
Biocompatibility: Cytotoxicity testing | ISO 10993-5 (2009) | Met |
Biocompatibility: Hemolysis testing (human activated and indirect) | ISO 10993-4 (2002 Amd 2006) | Met |
Biocompatibility (leveraged from predicate): Kligman Maximization Test | ISO 10993-10 (2002) | Met |
Biocompatibility (leveraged from predicate): Rabbit Pyrogen Test | ISO 10993-11 (2006) | Met |
Biocompatibility (leveraged from predicate): Intracutaneous Test | ISO 10993-10 (2002) | Met |
Biocompatibility (leveraged from predicate): Systemic Injection Test | ISO 10993-11 (2006) | Met |
Biocompatibility (leveraged from predicate): Complement Activation Assay | ISO 10993-4 (2002) | Met |
Biocompatibility (leveraged from predicate): UPTT | ISO 10993-4 (2002) | Met |
Biocompatibility (leveraged from predicate): Thrombogenicity In vivo canine | ISO 10993-4 (2002) | Met |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state specific sample sizes for each test in the test set. However, it mentions "representative finished sterilized samples" were used for in vivo, ex vivo animal testing, biocompatibility, and mechanical testing. The data provenance is primarily through a series of standardized tests (ISO, USP, AAMI TIR). The source of the animal models for in vivo testing is not specified, but the human cells for hemolysis testing and canine for thrombogenicity testing are mentioned. It is implicitly a prospective study since testing was performed on the modified device to demonstrate performance.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
Not applicable. This is a medical device, and the "ground truth" for performance is established through adherence to engineering standards and physical/biological test results, not expert interpretation of data.
4. Adjudication Method for the Test Set
Not applicable. This is a medical device, and the "adjudication" is based on meeting predefined technical and biological specifications outlined in the referenced standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No, an MRMC comparative effectiveness study was not done as this is a medical device and not an AI-assisted diagnostic tool.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Yes, the device performance was evaluated in a standalone manner through various functional, mechanical, and biocompatibility tests. There is no "human-in-the-loop" aspect to these performance assessments, as they measure the intrinsic properties and behavior of the device itself.
7. The Type of Ground Truth Used
The ground truth used for this device's acceptance is based on an objective assessment of physical and biological properties against established industry standards and regulatory guidance. This includes:
- Engineering standards compliance: ISO 11070 for mechanical tests.
- Biocompatibility standards compliance: ISO 10993 series and USP 33 .
- Effectiveness of sterilization: AAMI TIR28:2001.
8. The Sample Size for the Training Set
Not applicable. This is a physical medical device, not an AI/algorithm-based system requiring a training set.
9. How the Ground Truth for the Training Set Was Established
Not applicable. As there is no training set, there is no ground truth established for one.
Ask a specific question about this device
Page 1 of 1